Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Nieves Law Firm Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies
-
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
-
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
-
Turnbridge Equities Acquires Skyhouse Raleigh and Plans Comprehensive Renovation
-
SolarWindow CEO Issues Letter to Shareholders on Commercialization Strategy and Progress
-
T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR JULY 2026
-
Vanguard's New Customizable Model Portfolios Streamline Portfolio Personalization for Financial Advisors
-
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
-
MAMMOTION Celebrates 10th Anniversary with Limited-Time Savings on Robotic Lawn Mowers and Pool Cleaners
-
Leviathan Metals provides update on its diamond drilling program at the Central Project, Kalahari Copper Belt, Botswana
-
Tris Pharma Expands Support for People Living with ADHD Through New Partnerships with Calm Health and ADHD Central
-
Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot
-
Challenges and Opportunities in Real-Time Clinical Trials, Upcoming Webinar Hosted by Xtalks
-
As Higher Ed Faces an Enrollment Cliff, Transfer Students Are One Answer--If Institutions Can Process Them Fast Enough
-
Victory Marine Holdings’ DGBH Appoints Miles Bodie Director of E-Commerce to Lead Next Phase of GUTSI™ Omnichannel Growth
-
TKO Group Holdings to Participate in the Goldman Sachs Communacopia + Technology Conference
-
VanEck Launches Trading Card Game to Advance Financial Literacy Among Young Investors
-
Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease
-
Churchill Asset Management Launches Capital Solutions Strategy, Appoints Noah Charney to Lead Business
-
Clean Harbors to Acquire EnviroServe for $470 Million
-
Cineverse Launches VAUDIO™ to Help Brands Expand Audio Campaigns to CTV
-
Noble Secures New Patent for AI-Powered Sound Detection in Drug Delivery and Diagnostic Devices
-
biomodal Launches duet mosaic Giving Liquid Biopsy Researchers and Developers More Signal from Every Blood Draw
-
Guinness Atkinson Launches Global Innovators ETF Share Class (GAIQ)
-
Approximately 600 Registrants Draw Attention: Public- and Private-Sector Representatives Discuss the Present Status and Future of Regional School Sports Club Development
-
Intuit Advances Its Mid-Market Platform With Conversational AI, Enterprise Scale, and Deep Industry Workflows for CFOs and Accounting Firms
-
Mora Energy Completes Two Permian Basin Acquisitions and Enhances Capitalization
-
Sumitomo Pharma America Announces First Patient Receives Treatment in Phase 1/2a Study for its Investigational Therapy DSP-3077 for Retinitis Pigmentosa
-
Infosec Institute’s AI Cyber Readiness Summit Brings Security Leaders Together to Build AI-Ready Teams
-
Sionic Launches Instant Bank Pay in U.S. Through Microsoft Marketplace
-
GlobalMed® and Iveda Partner to Bring Intelligent, Mission-Ready Technology to Government Agencies
-
Neurocrine Biosciences Announces Publication of KINECT-PRO™ Findings Demonstrating INGREZZA® (valbenazine) Capsules Improved Patient-Reported Quality of Life and Daily Functioning for People Living
-
Mantis Space Names Former Boeing Technical Fellow Dale Parkes as Chief Technology Officer
-
Nakamoto Launches Intelligence 2027, a New Flagship Event for the AI Economy
-
Kioxia and Sandisk Unveil New High-Performance QLC 3D Flash Memory Technology Designed for AI and Data-Intensive Applications
-
Heaviside Industries Announces Nammo Partnership, $60 Million Series B
-
UNIFI®, Makers of REPREVE®, Schedules Fourth Quarter Fiscal 2026 Earnings Conference Call
-
Bath & Body Works to Report Second Quarter Results on August 26, 2026
-
Cheniere Highlights 10 Years of LNG Exports in 2025 Corporate Responsibility Report
-
Schwab Announces Single Stock Futures, Giving Retail Traders a New Way to Express Views on U.S. Stocks Around the Clock
-
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
-
Lovelace Establishes Strategic Advisory Board to Guide Growth in Mission-Critical AI
-
Improve Drug Solubility from Formulation to Scale-Up, Upcoming Webinar Presented by Quotient Sciences and NGT Biopharma Consultants, Hosted by Xtalks
-
PN Smart Energy Signs Framework Agreement to Acquire 9.9 MW Solar Portfolio
-
Odysight.ai to Participate in Upcoming Investor Conferences
-
TestMu AI Launches One-Click Migration From qTest to Test Manager
-
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
-
Founder Group Limited Secures Second Aquaculture Contract, a US$1.4 million 1.78 MW rooftop system for a Kedah shrimp Farm
-
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
-
Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes
